Earnings calendar/GLUE
Monte Rosa Therapeutics, Inc. (GLUE)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.36
Street estimate
Revenue target
$18.9M
Street estimate
Trailing EPS (avg 4Q)
$-0.44
Beat rate last 4: 25%
Latest EPS YoY
-186.7%
vs 2025-08-07
Latest revenue YoY
-61.2%
How results look so far
Trailing revenue (avg 4Q)
$7.2M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.43 / $-0.38
-13.0%
Revenue actual / est
$9.0M / $12.9M
-30.3%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.36 | Pending | — | $18.9M | Pending | — |
| 8/6/2026 | $-0.38 | $-0.43 | -13.0% | $12.9M | $9.0M | -30.3% |
| 5/14/2026upcoming | $-0.36 | Pending | — | $13.6M | Pending | — |
| 5/7/2026 | $-0.28 | $-0.45 | -60.7% | $11.0M | $4.2M | -61.7% |
| 3/19/2026upcoming | $-0.45 | Pending | — | $17.1M | Pending | — |
| 3/17/2026 | $-0.35 | $-0.54 | -53.6% | $15.6M | $2.8M | -82.0% |
| 11/6/2025 | $-0.37 | $-0.33 | +9.9% | $15.5M | $12.8M | -17.7% |
| 8/7/2025 | $-0.38 | $-0.15 | +60.2% | $7.8M | $23.2M | +198.4% |
| 5/8/2025 | $-0.00 | $0.57 | +22023.1% | $13.6M | $84.9M | +526.0% |
| 3/20/2025 | $0.02 | $0.23 | +1374.4% | $46.7M | $60.6M | +30.0% |
| 11/7/2024 | $-0.49 | $-0.29 | +40.8% | $2.6M | $9.2M | +249.3% |
| 8/8/2024 | $-0.54 | $-0.43 | +20.4% | $1.3M | $4.7M | +248.1% |
| 5/9/2024 | $-0.57 | $-0.53 | +7.0% | $1.4M | $1.1M | -24.0% |
| 3/14/2024 | $-0.33 | $-0.58 | -75.8% | $3.5M | Pending | — |
| 11/9/2023 | $-0.72 | $-0.70 | +2.8% | — | Pending | — |
| 8/10/2023 | $-0.70 | $-0.71 | -1.4% | — | Pending | — |
| 5/11/2023 | $-0.68 | $-0.65 | +4.4% | — | Pending | — |
| 3/16/2023 | $-0.62 | $-0.63 | -1.6% | — | Pending | — |
| 11/10/2022 | $-0.60 | $-0.58 | +3.3% | — | Pending | — |
| 8/11/2022 | $-0.54 | $-0.57 | -5.6% | — | Pending | — |
| 5/11/2022 | $-0.52 | $-0.51 | +1.9% | — | Pending | — |
| 3/29/2022 | $-0.50 | $-0.93 | -86.0% | — | Pending | — |
| 11/10/2021 | $-0.44 | $-0.43 | +2.3% | — | Pending | — |
| 8/12/2021 | $-0.40 | $-3.63 | -807.5% | — | Pending | — |
| 6/25/2021 | — | $-0.29 | — | — | Pending | — |
| 3/31/2021 | — | $-0.29 | — | — | Pending | — |
| 12/31/2020 | — | $-0.90 | — | — | Pending | — |
| 9/30/2020 | — | $-0.30 | — | — | Pending | — |
| 6/30/2020 | — | $-0.25 | — | — | Pending | — |
| 3/31/2020 | — | $-0.20 | — | — | Pending | — |